Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Tim Clayton

Rationale and Design of the EMPERIAL-Preserved and EMPERIAL-Reduced Trials of Empagliflozin in Patients With Chronic Heart Failure

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

Evaluation of the Effect of Sodium–glucose Co‐transporter 2 Inhibition With Empagliflozin on Morbidity and Mortality of Patients With Chronic Heart Failure and a Reduced Ejection Fraction: Rationale for and Design of the EMPEROR‐Reduced Trial

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

Evaluation of the Effects of Sodium–glucose Co‐transporter 2 Inhibition With Empagliflozin on Morbidity and Mortality in Patients With Chronic Heart Failure and a Preserved Ejection Fraction: Rationale for and Design of the EMPEROR‐Preserved Trial

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2019English

A 10-Year Prognostic Model for Patients With Suspected Angina Attending a Chest Pain Clinic

Heart
Cardiovascular MedicineCardiology
2016English

Effect of Herpes Simplex Suppression on Incidence of HIV Among Women in Tanzania

New England Journal of Medicine
Medicine
2008English

Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: Six-Year Follow-Up From the Stent or Surgery Trial (SoS)

Circulation
Cardiovascular MedicinePhysiologyCardiology
2008English

Risk Factors for HIV Incidence in Women Participating in an HSV Suppressive Treatment Trial in Tanzania

AIDS
Infectious DiseasesAllergyImmunology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy